Literature DB >> 10677756

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.

S Sosa Estani1, E L Segura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10677756     DOI： 10.1590/s0074-02761999000700070

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  10 in total

1.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

2.  Emerging parasitic infections in transplantation.

Authors:  Roberta Lattes; Laura Linares; Marcelo Radisic
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 3.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.

Authors:  Paulo M M Guedes; Fabiana S Oliveira; Fredy R S Gutierrez; Grace Kelly da Silva; Gerson Jhonatan Rodrigues; Lusiane Maria Bendhack; Douglas W Franco; Maria A Do Valle Matta; Dario S Zamboni; Roberto Santana da Silva; João Santana Silva
Journal:  Br J Pharmacol       Date:  2010-01-27       Impact factor: 8.739

Review 5.  Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.

Authors:  Facundo Garcia-Bournissen; Jaime Altcheh; Norberto Giglio; Guido Mastrantonio; Carlos Omar Della Védova; Gideon Koren
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.

Authors:  Patricia S Doyle; Yuan M Zhou; Juan C Engel; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

7.  Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.

Authors:  Jaime Altcheh; Guillermo Moscatelli; Guido Mastrantonio; Samanta Moroni; Norberto Giglio; Maria Elena Marson; Griselda Ballering; Margarita Bisio; Gideon Koren; Facundo García-Bournissen
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22

8.  Synthesis, characterization and in vitro antitrypanosomal activities of new carboxamides bearing quinoline moiety.

Authors:  David Izuchukwu Ugwu; Uchechukwu Chris Okoro; Narendra Kumar Mishra
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.

Authors:  Lívia de Figueiredo Diniz; Julio A Urbina; Isabel Mayer de Andrade; Ana Lia Mazzeti; Tassiane Assíria F Martins; Ivo Santana Caldas; André Talvani; Isabela Ribeiro; Maria Terezinha Bahia
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15

10.  Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.

Authors:  Abilio Augusto Fragata-Filho; Francisco Faustino França; Claudia da Silva Fragata; Angela Maria Lourenço; Cristiane Castro Faccini; Cristiane Aparecida de Jesus Costa
Journal:  PLoS Negl Trop Dis       Date:  2016-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.